Heterogeneity of Multiple System Atrophy: An Update
Open Access
- 3 March 2022
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (3) , 599
Abstract
Multiple system atrophy (MSA) is a fatal, rapidly progressing neurodegenerative disease of uncertain etiology, clinically characterized by various combinations of Levodopa unresponsive parkinsonism, cerebellar, autonomic and motor dysfunctions. The morphological hallmark of this α-synucleinopathy is the deposition of aberrant α-synuclein in both glia, mainly oligodendroglia (glial cytoplasmic inclusions /GCIs/) and neurons, associated with glioneuronal degeneration of the striatonigral, olivopontocerebellar and many other neuronal systems. Typical phenotypes are MSA with predominant parkinsonism (MSA-P) and a cerebellar variant (MSA-C) with olivocerebellar atrophy. However, MSA can present with a wider range of clinical and pathological features than previously thought. In addition to rare combined or “mixed” MSA, there is a broad spectrum of atypical MSA variants, such as those with a different age at onset and disease duration, “minimal change” or prodromal forms, MSA variants with Lewy body disease or severe hippocampal pathology, rare forms with an unusual tau pathology or spinal myoclonus, an increasing number of MSA cases with cognitive impairment/dementia, rare familial forms, and questionable conjugal MSA. These variants that do not fit into the current classification of MSA are a major challenge for the diagnosis of this unique proteinopathy. Although the clinical diagnostic accuracy and differential diagnosis of MSA have improved by using combined biomarkers, its distinction from clinically similar extrapyramidal disorders with other pathologies and etiologies may be difficult. These aspects should be taken into consideration when revising the current diagnostic criteria. This appears important given that disease-modifying treatment strategies for this hitherto incurable disorder are under investigation.Keywords
Funding Information
- Society for the Promotion of Research in Experimental Neurology, Vienna, Austria (001)
This publication has 168 references indexed in Scilit:
- Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in NeuronsCell, 2013
- The natural history of multiple system atrophy: a prospective European cohort studyThe Lancet Neurology, 2013
- The neuropathology, pathophysiology and genetics of multiple system atrophyNeuropathology and Applied Neurobiology, 2012
- Interaction between -Synuclein and Other Proteins in Neurodegenerative DisordersThe Scientific World Journal, 2011
- Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registryMovement Disorders, 2010
- Cognitive and Neuropsychiatric Profile of the SynucleinopathiesAlzheimer Disease & Associated Disorders, 2009
- Second consensus statement on the diagnosis of multiple system atrophyNeurology, 2008
- Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?Acta Neuropathologica, 2008
- Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophyNeuropathology and Applied Neurobiology, 2007
- ?Minimal change? multiple system atrophyMovement Disorders, 1994